What's new in pediatric dermatology? Part II. Treatment

Howard B. Pride, Megha Tollefson, Robert Silverman

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.

Original languageEnglish (US)
Pages (from-to)899.e1-899.e11
JournalJournal of the American Academy of Dermatology
Issue number6
StatePublished - Jun 2013


  • acne
  • atopic dermatitis
  • eczema herpeticum
  • general anesthesia
  • hemangioma
  • herpes simplex
  • isotretinoin
  • lymphangioma
  • neonatal herpes simplex
  • pediatric dermatology
  • propranolol
  • rapamycin
  • texting
  • tinea capitis
  • vascular malformation

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'What's new in pediatric dermatology? Part II. Treatment'. Together they form a unique fingerprint.

Cite this